Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Document Type
Journal Article
Publication Date
6-4-2020
Journal
The New England Journal of Medicine
Volume
382
Issue
23
Inclusive Pages
2207-2219
DOI
10.1056/NEJMoa1915315
APA Citation
Minard-Colin, V., Aupérin, A., Pillon, M., Burke, G., Barkauskas, D., Wheatley, K., Delgado, R., Alexander, S., Uyttebroeck, A., Bollard, C. M., Zsiros, J., Csoka, M., Kazanowska, B., Chiang, A., Miles, R., Wotherspoon, A., Adamson, P., Vassal, G., Patte, C., & Gross, T. (2020). Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.. The New England Journal of Medicine, 382 (23). http://dx.doi.org/10.1056/NEJMoa1915315
Peer Reviewed
1
